Gene · 3908
Papers2,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-Exome Sequencing-Based Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Pedigrees. | Cancers (Basel) | 2025 | 41300981 | PubTator, text mining | PubMed |
| The extracellular matrix in peripheral nerve repair and regeneration: a narrative review of its role and therapeutic potential. | Front Neuroanat | 2025 | 41194908 | PubTator, text mining | PubMed |
| A novel compound heterozygous variant in LAMA2 gene in a family with merosin-deficient congenital muscular dystrophy. | BMC Med Genomics | 2025 | 41188926 | PubTator, text mining | PubMed |
| Spatial proteomics reveals recombinant human laminin-111 restores adhesion signaling to laminin-α2-deficient muscle. | JCI Insight | 2025 | 41118381 | PubTator, text mining | PubMed |
283rd ENMC international workshop: Establishing expert care recommendations for LAMA2-RD: A prototype for the development of congenital muscular dystrophy subtype-specific care guidelines. Hoofddorp, The Netherlands, January 17th-19th 2025. | Neuromuscul Disord | 2025 | 41106238 | PubTator, text mining | PubMed |
| A novel mouse model for LAMA2-related muscular dystrophy with analysis of molecular pathogenesis and clinical phenotype. | Elife | 2025 | 40960171 | PubTator, text mining | PubMed |
| Broadening the paradigm of laminin α2-related muscular dystrophy: A case of partial merosin deficiency with compound heterozygous variants. | SAGE Open Med Case Rep | 2025 | 40874012 | PubTator, text mining | PubMed |
| Genetic and Clinical Spectrum of Limb-Girdle Muscular Dystrophies in Western Sicily. | Genes (Basel) | 2025 | 40870035 | PubTator, text mining | PubMed |
| Molecular profiles of the great obstetrical syndromes reveal common features and dynamic changes in early pregnancy. | Commun Med (Lond) | 2025 | 40855186 | PubTator, text mining | PubMed |
| Apelin as a CNS-specific pathway for fenestrated capillary formation in the choroid plexus. | Nat Commun | 2025 | 40830138 | PubTator, text mining | PubMed |
| Identification of foam cell like M2 macrophages, AEBP1 biomarkers, and resveratrol as potential therapeutic in MASLD using Ecotyper and WGCNA. | Sci Rep | 2025 | 40825823 | PubTator, text mining | PubMed |
| A Novel LAMA2 Mutation (c.7412G>A) Was Found in a Chinese Patient With Congenital Muscular Dystrophy. | J Cell Mol Med | 2025 | 40751275 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | 40740483 | PubTator, text mining | PubMed |
| Transcriptional Insights into Anti-Adhesion of Human Milk Oligosaccharides Against E. coli O157:H7: Decoy Effects and Immunomodulatory. | J Agric Food Chem | 2025 | 40613459 | PubTator, text mining | PubMed |
| Loss of integrin alpha7-mediated signaling induces a dendritic cell-like phenotype in macrophages cultured on laminin-211/221 isoforms. | J Biol Chem | 2025 | 40578559 | PubTator, text mining | PubMed |
| Integrative multi-omics study identifies sex-specific molecular signatures and immune modulation in bladder cancer. | Front Bioinform | 2025 | 40458476 | PubTator, text mining | PubMed |
| Investigating the dual role of mitochondrial and nuclear genome variants in pediatric cardiomyopathies. | Sci Rep | 2025 | 40369053 | PubTator, text mining | PubMed |
| A survey on mutation spectrum in Iranian patients with limb-girdle muscular dystrophies. | Hum Genomics | 2025 | 40361203 | PubTator, text mining | PubMed |
| Atypical Presentation of Congenital Muscular Dystrophy: A LAMA2 Related Muscular Dystrophy. | J Child Neurol | 2025 | 40296707 | PubTator, text mining | PubMed |
| Increased HSD11β1 Expression in Human Leiomyomatous Uteri: Implication for Enhanced Glucocorticoid Signaling. | J Clin Endocrinol Metab | 2025 | 40290045 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3908/papers?page=4